Sharechat Logo

NZ commodity prices rise in December, led by cheese, butter, milk powder

Thursday 9th January 2014

Text too small?

New Zealand commodity prices rose in December, led by gains in dairy products.

The ANZ Commodity Price Index advanced 1 percent to 330.4 from November, touching its second highest level on record. The index is about 22 percent above December 2012.

International prices for 10 of New Zealand's main commodities increased in the month, three fell and four were unchanged.

Cheese and butter prices led the gains, up 7 percent, with cheese at its highest in more than five years and butter lifting to a two-year high. Skim and whole milk powders showed the next largest price rises, up 3 and 2 percent respectively.

The price of logs, seafood and sawn timber increased 1 percent, while the prices of casein, beef and lamb increased by 0.5 percent or less. Wool prices fell from November's two-year high, down 12 percent, while pelts dropped 4 percent and aluminium prices eased 1 percent.

In New Zealand dollar terms, the index lifted 1.7 percent to its fourth-highest level on record.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

RAD - Radius Care Expansion Continues with Care Home Acquisition
PFI - Property for Industry Limited Bond Offer Final Terms Sheet
April 1st Morning Report
FSF - Fonterra completes sale of Mainland Group to Lactalis
GNE - Resignation of Chief Financial Officer
PFI - Property for Industry Limited Launches Bond Offer
March 30th Morning Report
HGH Ltd Results for the 6 months ended 1 February 2026
March 27th Morning Report
CDC investor presentation and guidance update